In Meniere's disease Ménière’s disease is a disorder of the inner ear that causes severe dizziness (vertigo), ringing in the ears (tinnitus), hearing loss, and a feeling of congestion in the ear. This is due to build-up of fluid in the inner ear. Betacitam Tablet reduces the amount of fluid and prevents symptoms from developing. It may take a couple of weeks before you notice any improvements but keep taking it, even if you do feel better, until your doctor advises it is safe to stop.
Caution is advised when consuming alcohol with Betacitam Tablet. Please consult your doctor.
Betacitam Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Betacitam Tablet during breastfeeding is not available. Please consult your doctor.
Betacitam Tablet may cause side effects which could affect your ability to drive. Betacitam Tablet may cause drowsiness and shakiness. This may affect your driving ability.
Betacitam Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Betacitam Tablet may not be needed in these patients. Please consult your doctor.
Betacitam Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Betacitam Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Betacitam Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Ordain Health Care Global Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vasu Organics Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Septalyst Lifesciences Pvt.Ltd. || ₹14.5/tablet (25% cheaper)